Biopharmaceutics delves into the complex connection between the physical and chemical attributes of drugs and their optimal dosages, influencing drug action. It entails evaluating how a drug's physicochemical features and its formulation affect bioavailability and therapeutic effects. This field scrutinizes the intricate interplay among a drug's properties, its biological fate post-administration, and the consequent pharmacological actions.
Biopharmaceutics places significant emphasis on comprehending critical physicochemical properties, playing a pivotal role in optimizing drug formulations for heightened efficacy and ensuring successful therapeutic outcomes. It investigates the dynamic interplay between a drug's properties, its biological fate after administration, and the resulting pharmacological actions.
By thoroughly assessing these factors, biopharmaceutics aims to enhance our understanding of drug behavior in the body, ultimately contributing to the development of more effective and tailored drug formulations. This discipline serves as a cornerstone for pharmaceutical advancements, guiding the design and optimization of drug delivery systems to maximize therapeutic benefits. Biopharmaceutics plays a crucial role in bridging the gap between drug development and clinical application, fostering advancements in pharmacotherapy for improved patient outcomes.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico